Article: Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women

File Download Links for fulltext
(May Require Subscription)
  • Basic View
  • Metadata View
  • XML View
TitleFunctional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women
AuthorsChan, KYK3
Liu, W3 6
Long, JR2
Yip, SP5
Chan, SY3
Shu, XO2
Chua, DTT3
Cheung, ANY3
Ching, JCY3
Cai, H2
Au, GKH3
Chan, M1
Foo, W4
Ngan, HYS3
Gao, YT7
Ngan, ESW3
GarciaBarceló, MM3
Zheng, W2
Khoo, US3
Issue Date2009
PublisherBMJ Group. The Journal's web site is located at http://jmg.bmj.com/
CitationJournal Of Medical Genetics, 2009, v. 46 n. 1, p. 32-39 [How to Cite?]
DOI: http://dx.doi.org/10.1136/jmg.2007.057174
AbstractBackground: The BRCA1 gene is an important breast-cancer susceptibility gene. Promoter polymorphisms can alter the binding affinity of transcription factors, changing transcriptional activity and may affect susceptibility to disease. Methods and Results: Using direct sequencing of the BRCA1 promoter region, we identified four polymorphisms c.-2804T→C (rs799908:T→C), c.-2265C→T (rs11655505:C→T), c.-2004A→G (rs799906:A→G) and c.-1896(ACA) 1→(ACA) 2 (rs8176071:(ACA) 1→(ACA) 2) present in Hong Kong Chinese. Each polymorphism was studied independently and in combination by functional assays. Although all four variants significantly altered promoter activity, the c.-2265T allele had stronger binding than the C allele, and the most common mutant haplotype, which contains the c.-2265T allele, increased promoter activity by 70%. Risk association first tested in Hong Kong Chinese women with breast cancer and age-matched controls and replicated in a large population-based study of Shanghai Chinese, together totalling >3000 participants, showed that carriers of the c.-2265T allele had a reduced risk for breast cancer (combined odd ratio (OR) = 0.80, 95% Cl 0.69 to 0.93; p = 0.003) which was more evident among women aged ≥45 years at first diagnosis of breast cancer and without a family history of breast cancer (combined OR = 0.75, 95% Cl 0.61 to 0.91; p = 0.004). The most common haplotype containing the c.-2265T allele also showed significant risk association for women aged ≥45 years without a family history of breast cancer (OR = 0.64, 95% Cl 0.46 to 0.89; p = 0.008). Conclusion: This comprehensive study of BRCA1 promoter polymorphisms found four variants that altered promoter activity and with the most significant contribution from c.-2265C→T, which could affect susceptibility to breast cancer in the Chinese population. Its significance in other populations remains to be investigated.
ISSN0022-2593
2011 Impact Factor: 6.365
2011 SCImago Journal Rankings: 0.841
DOIhttp://dx.doi.org/10.1136/jmg.2007.057174
ISI Accession Number IDWOS:000262198000005
Funding AgencyGrant Number
Research Grant Council, Hong Kong SAR, ChinaHKU 7520/05M
University of Hong Kong200711159018
National Cancer InstituteRO1CA64277
RO1CA90899
Funding Information:

This study was funded by the Research Grant Council, Hong Kong SAR, China, (project code HKU 7520/05M) and the Committee on Research and Conference Grants from the University of Hong Kong (project code 200711159018). The Shanghai Breast Cancer Study is supported by RO1CA64277 and RO1CA90899 from the National Cancer Institute.

PubMed Central IDPMC2782922
ReferencesReferences in Scopus
GrantsIdentification of transcriptional factors interacting with the BRCA1 promoter
Gene-based and haplotype analysis of the estrogen receptor genes for breast cancer susceptibility
Gene-based and haplotype analysis of the estrogen receptor genes for breast cancer susceptibility
DC Field
Value
dc.contributor.authorChan, KYK
dc.contributor.authorLiu, W
dc.contributor.authorLong, JR
dc.contributor.authorYip, SP
dc.contributor.authorChan, SY
dc.contributor.authorShu, XO
dc.contributor.authorChua, DTT
dc.contributor.authorCheung, ANY
dc.contributor.authorChing, JCY
dc.contributor.authorCai, H
dc.contributor.authorAu, GKH
dc.contributor.authorChan, M
dc.contributor.authorFoo, W
dc.contributor.authorNgan, HYS
dc.contributor.authorGao, YT
dc.contributor.authorNgan, ESW
dc.contributor.authorGarciaBarceló, MM
dc.contributor.authorZheng, W
dc.contributor.authorKhoo, US
dc.date.accessioned2010-05-31T03:33:17Z
dc.date.available2010-05-31T03:33:17Z
dc.date.issued2009
dc.description.abstractBackground: The BRCA1 gene is an important breast-cancer susceptibility gene. Promoter polymorphisms can alter the binding affinity of transcription factors, changing transcriptional activity and may affect susceptibility to disease. Methods and Results: Using direct sequencing of the BRCA1 promoter region, we identified four polymorphisms c.-2804T→C (rs799908:T→C), c.-2265C→T (rs11655505:C→T), c.-2004A→G (rs799906:A→G) and c.-1896(ACA) 1→(ACA) 2 (rs8176071:(ACA) 1→(ACA) 2) present in Hong Kong Chinese. Each polymorphism was studied independently and in combination by functional assays. Although all four variants significantly altered promoter activity, the c.-2265T allele had stronger binding than the C allele, and the most common mutant haplotype, which contains the c.-2265T allele, increased promoter activity by 70%. Risk association first tested in Hong Kong Chinese women with breast cancer and age-matched controls and replicated in a large population-based study of Shanghai Chinese, together totalling >3000 participants, showed that carriers of the c.-2265T allele had a reduced risk for breast cancer (combined odd ratio (OR) = 0.80, 95% Cl 0.69 to 0.93; p = 0.003) which was more evident among women aged ≥45 years at first diagnosis of breast cancer and without a family history of breast cancer (combined OR = 0.75, 95% Cl 0.61 to 0.91; p = 0.004). The most common haplotype containing the c.-2265T allele also showed significant risk association for women aged ≥45 years without a family history of breast cancer (OR = 0.64, 95% Cl 0.46 to 0.89; p = 0.008). Conclusion: This comprehensive study of BRCA1 promoter polymorphisms found four variants that altered promoter activity and with the most significant contribution from c.-2265C→T, which could affect susceptibility to breast cancer in the Chinese population. Its significance in other populations remains to be investigated.
dc.description.grantIdentification of transcriptional factors interacting with the BRCA1 promoter
dc.description.grantGene-based and haplotype analysis of the estrogen receptor genes for breast cancer susceptibility
dc.description.grantGene-based and haplotype analysis of the estrogen receptor genes for breast cancer susceptibility
dc.description.grantcode97870
dc.description.grantcode29671
dc.description.grantcode28077
dc.description.naturepublished_or_final_version
dc.identifier.citationJournal Of Medical Genetics, 2009, v. 46 n. 1, p. 32-39 [How to Cite?]
DOI: http://dx.doi.org/10.1136/jmg.2007.057174
dc.identifier.doihttp://dx.doi.org/10.1136/jmg.2007.057174
dc.identifier.epage39
dc.identifier.hkuros166040
dc.identifier.isiWOS:000262198000005
Funding AgencyGrant Number
Research Grant Council, Hong Kong SAR, ChinaHKU 7520/05M
University of Hong Kong200711159018
National Cancer InstituteRO1CA64277
RO1CA90899
Funding Information:

This study was funded by the Research Grant Council, Hong Kong SAR, China, (project code HKU 7520/05M) and the Committee on Research and Conference Grants from the University of Hong Kong (project code 200711159018). The Shanghai Breast Cancer Study is supported by RO1CA64277 and RO1CA90899 from the National Cancer Institute.

dc.identifier.issn0022-2593
2011 Impact Factor: 6.365
2011 SCImago Journal Rankings: 0.841
dc.identifier.issue1
dc.identifier.openurl
dc.identifier.pmcidPMC2782922
dc.identifier.pmid18782836
dc.identifier.scopuseid_2-s2.0-58549086564
dc.identifier.spage32
dc.identifier.urihttp://hdl.handle.net/10722/58601
dc.identifier.volume46
dc.languageeng
dc.publisherBMJ Group. The Journal's web site is located at http://jmg.bmj.com/
dc.publisher.placeUnited Kingdom
dc.relation.ispartofJournal of Medical Genetics
dc.relation.referencesReferences in Scopus
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License
dc.subject.meshBRCA1 Protein - genetics
dc.subject.meshBreast Neoplasms - epidemiology - genetics
dc.subject.meshPolymorphism, Genetic - genetics
dc.subject.meshPromoter Regions, Genetic - genetics
dc.subject.meshTranscription, Genetic
dc.titleFunctional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women
dc.typeArticle
Author Affiliations
  1. Kwong Wah Hospital
  2. Vanderbilt Ingram Cancer Center
  3. The University of Hong Kong Li Ka Shing Faculty of Medicine
  4. Queen Elizabeth Hospital Hong Kong
  5. Hong Kong Polytechnic University
  6. Soochow University
  7. null